Sign in
4

Changes in Ownership

Skye Bioscience, Inc. Filed Acc 0001628280-21-018754

Options or other derivatives

  • Director acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

TYLE PRAVEEN · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-14 Grant or award : show line 1 in the form Director Stock Option (Right to Buy) +25,000 275,000 D
Loading xslF345X03/wf-form4_163182245212535.xml…